WHEN DERMATITIS INFLAMMATION AND IRRITATION PRESENT FIGHT BACK with BENSAL HP® ACCELERATED WOUND HEALING FOR SKIN-BARRIER BREAKS*   *BENSAL HP substantially increased the rate of re-epithelialization in a study of 13 healthy human volunteers by 63% over the vehicle alone (P<0.01) and 77% over untreated control (P<0.005)1     Dermatitis procedures with potential applications for BENSAL HP†         Mohs surgery2     Cryotherapy3     Basal cell removal4       Images shown are for illustrative purposes only.     † BENSAL HP has not been studied in patients with these conditions. This list is not inclusive of all potential applications.   For more information on BENSAL HP, or for product samples and patient savings, visit our website at www.bensalhprx.com.   Ingredients BENSAL HP contains 30 mg salicylic acid per gram in a base containing benzoic acid, oak bark extract (QRB-7), and polyethylene glycol 400 and 3350.1 • Available in 30-g tubes • Dosed twice daily (BID) Indications and Usage An external treatment for the inflammation and irritation associated with many common forms of dermatitis, including certain eczematoid conditions. These conditions include complications associated with pyodermas. Indicated also in the treatment of insect bites, burns, and fungal infections. Important Safety Information • BENSAL HP is contraindicated for use in those patients who are hypersensitive to topical polyethylene glycols. • BENSAL HP is for external use only. Not to be used in eyes. • It is not known if BENSAL HP interacts with other topical medications applied to the treatment area. Use with other topical agents has not been studied. • A small percentage of patients may experience a temporary burning sensation upon application of the ointment. • Safety and effectiveness in pediatric patients has not been established.   Please click here to view the full Prescribing Information for BENSAL HP.       References: 1. BENSAL HP [prescribing information]. Easley, SC: 7 Oaks Pharmaceutical Corp; 2010. 2. Mohs surgery. Mayo Clinic website. http://www.mayoclinic.org/tests-procedures/mohssurgery/basics/definition/prc-20014261. 2012. Accessed June 13, 2014. 3. Cryotherapy. US National Library of Medicine website. http://www.nlm.nih.gov/medlineplus/ency/article/007506.htm. 2012. Accessed June 13, 2014. 4. Excision for Nonmelanoma Skin Cancer. WebMD website. http://www.webmd.com/cancer/excision-for-nonmelanoma-skin-cancer. 2012. Accessed June 13, 2014.   You have the right to opt out of receiving unsolicited advertisements by email. You may contact us with your opt-out request, along with the email to which your request relates, by telephone at 1-877-540-6501, or by submitting your request to valeantorder@corpcomm.com. Opt-out requests will be honored within 30 days of receipt. Please be sure to indicate the email address to which your request relates and reason for opt-out.             The BENSAL HP trademark is used under license. Except where otherwise indicated, all other products, names, slogans, and other marks are trademarks of the Valeant family of companies.   © 2014 Valeant Pharmaceuticals North America LLC. DM/BHP/14/0054